Pulmatrix Statistics
Share Statistics
Pulmatrix has 3.65M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 3.65M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 8.88% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 434 |
| FTD / Avg. Volume | 1.8% |
Short Selling Information
The latest short interest is 23.83K, so 0.65% of the outstanding
shares have been sold short.
| Short Interest | 23.83K |
| Short % of Shares Out | 0.65% |
| Short % of Float | 0.66% |
| Short Ratio (days to cover) | 2.91 |
Valuation Ratios
The PE ratio is -2.67 and the forward
PE ratio is -2.77.
Pulmatrix's PEG ratio is
0.08.
| PE Ratio | -2.67 |
| Forward PE | -2.77 |
| PS Ratio | 3.27 |
| Forward PS | 0.8 |
| PB Ratio | 2.85 |
| P/FCF Ratio | -2.29 |
| PEG Ratio | 0.08 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Pulmatrix.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.68,
with a Debt / Equity ratio of 0.
| Current Ratio | 10.68 |
| Quick Ratio | 10.68 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $3,903,000 |
| Profits Per Employee | $-4,779,500 |
| Employee Count | 2 |
| Asset Turnover | 0.79 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 248.31% in the
last 52 weeks. The beta is 1.38, so Pulmatrix's
price volatility has been higher than the market average.
| Beta | 1.38 |
| 52-Week Price Change | 248.31% |
| 50-Day Moving Average | 6.68 |
| 200-Day Moving Average | 4.88 |
| Relative Strength Index (RSI) | 46.79 |
| Average Volume (20 Days) | 24,096 |
Income Statement
In the last 12 months, Pulmatrix had revenue of 7.81M
and earned -9.56M
in profits. Earnings per share was -2.62.
| Revenue | 7.81M |
| Gross Profit | 7.37M |
| Operating Income | -9.76M |
| Net Income | -9.56M |
| EBITDA | -6.71M |
| EBIT | -7.14M |
| Earnings Per Share (EPS) | -2.62 |
Full Income StatementBalance Sheet
The company has 9.52M in cash and 0 in
debt, giving a net cash position of 9.52M.
| Cash & Cash Equivalents | 9.52M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -297.16M |
| Total Assets | 9.94M |
| Working Capital | 8.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -10.72M
and capital expenditures -398K, giving a free cash flow of -11.11M.
| Operating Cash Flow | -10.72M |
| Capital Expenditures | -398K |
| Free Cash Flow | -11.11M |
| FCF Per Share | -3.04 |
Full Cash Flow StatementMargins
Gross margin is 94.43%, with operating and profit margins of -125.07% and -122.46%.
| Gross Margin | 94.43% |
| Operating Margin | -125.07% |
| Pretax Margin | -122.46% |
| Profit Margin | -122.46% |
| EBITDA Margin | -85.96% |
| EBIT Margin | -125.07% |
| FCF Margin | -142.38% |
